Omitting ALND Is Not Safe for a Cohort of Early-Stage Breast Cancer Patients with 1–2 SLNs Macro-Metastases and Breast-Conserving Therapy: A Single-Center Retrospective Study

BACKGROUND: Omitting axillary lymph node dissection (ALND) is recommended for early-stage breast cancer patients with 1–2 sentinel lymph nodes (SLNs) macro-metastases and breast-conserving therapy. However, it is not safe for part of patients, so it is significant to find risk factors and develop a...

Descripción completa

Detalles Bibliográficos
Autores principales: WANG, Xiangyu, GAO, Yinqi, YANG, Xue, KONG, Xiangyi, WANG, Zixing, FANG, Yi, WANG, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548499/
https://www.ncbi.nlm.nih.gov/pubmed/33083292
http://dx.doi.org/10.18502/ijph.v49i7.3579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548499/
https://www.ncbi.nlm.nih.gov/pubmed/33083292
http://dx.doi.org/10.18502/ijph.v49i7.3579

Ejemplares similares